The FDA approved oral semaglutide (Wegovy) for weight loss and reducing major adverse cardiovascular events. Novo Nordisk plans to launch the once-daily oral semaglutide in the US in early January ...
U.S. regulators approved the first GLP-1 weight-loss pill—a tablet formulation of Novo Nordisk’s NOVO.B5.00%increase; green up pointing triangle Ozempic and Wegovy—ushering in a new era of the obesity ...
Serena Williams is using weight-loss medication, and people have a lot of thoughts about that. “I was never able to be at a healthy weight, whether it was my joints or blood sugar levels,” she said on ...
WeightWatchers is refreshing its brand identity and digital experiences as it moves to address the rise of GLP-1 weight-loss drugs, per details shared with Marketing Dive. Changes include a new logo ...
This story is from Manual, GQ’s flagship newsletter offering useful advice on style, health, and more, four days a week. Sign up here to get it in your inbox. Ever since man first picked up heavy ...
In 2023, Oprah Winfrey started using a GLP-1 weight-loss medication as "a tool to avoid yo-yoing" Emily Blackwood is a writer and editor at PEOPLE. She has been working at PEOPLE since 2023. Her work ...
The US Food and Drug Administration has approved Novo Nordisk’s once-daily weight-loss pill, making it the first oral glucagon-like peptide 1 (GLP-1) product available for weight management. The pill, ...
Dr. Valerie Cholet is a Professor of Kinesiology. She earned her doctorate at Penn State University and has taught in higher education for over 20 years. Her areas of specialization include Exercise ...
Kaitlin Sullivan is a health and science journalist based in Colorado. She's been part of multiple award-winning investigations into health topics including the international medical device industry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback